These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10926380)

  • 41. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles.
    Geller DE
    Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abbreviated aerosol therapy for improved efficiency.
    Mason JW; Miller WC
    J Aerosol Med; 1998; 11(3):127-31. PubMed ID: 10186958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analysis of causes of incorrect use of dose aerosols].
    Petro W; Gebert P; Lauber B
    Pneumologie; 1994 Mar; 48(3):191-6. PubMed ID: 8197077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacological perspectives].
    Fournier M; Guérin JC
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S64-5. PubMed ID: 9809350
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhaled triamcinolone and chronic obstructive pulmonary disease.
    Reid DW; Walters H
    N Engl J Med; 2001 May; 344(20):1554; author reply 1554-6. PubMed ID: 11368047
    [No Abstract]   [Full Text] [Related]  

  • 47. [Properties of small nebulizers and their suitability for aerosol therapy].
    Wolf M; Angerstein W
    Z Erkr Atmungsorgane; 1982; 159(2):210-4. PubMed ID: 7168215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of obstructive respiratory tract diseases. Staging therapy according to severity].
    Ulmer WT
    Fortschr Med; 1992 Nov; 110(32):607-8. PubMed ID: 1478599
    [No Abstract]   [Full Text] [Related]  

  • 49. [Bronchodilator nebulization in bronchial obstructions].
    Muir JF; Cuvelier A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S41-3. PubMed ID: 10088238
    [No Abstract]   [Full Text] [Related]  

  • 50. Aerosols for systemic delivery of macromolecules.
    Newhouse MT; Corkery KJ
    Respir Care Clin N Am; 2001 Jun; 7(2):261-75, vi. PubMed ID: 11517023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhaled bronchodilator administration during mechanical ventilation.
    Duarte AG
    Respir Care; 2004 Jun; 49(6):623-34. PubMed ID: 15165297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possibility of ocular absorption of nebuliser aerosols.
    Taylor RP
    Med J Aust; 1994 Nov; 161(9):576. PubMed ID: 7968773
    [No Abstract]   [Full Text] [Related]  

  • 55. [From COPD, COAD, CURS, CUSLK, CAO to CHAOS].
    Nolte D
    Med Klin (Munich); 1995 Jan; 90(1):1-2. PubMed ID: 7885298
    [No Abstract]   [Full Text] [Related]  

  • 56. Aerosolized bronchodilators in the intensive care unit: much ado about nothing?
    Smaldone GC
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1029-30. PubMed ID: 10194141
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of different inhalation modes on the efficacy of pressurized aerosol bronchodilators.
    Clarke SW; Pavia D; Newman SP
    Eur J Respir Dis Suppl; 1982; 119():79-88. PubMed ID: 6954091
    [No Abstract]   [Full Text] [Related]  

  • 58. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic treatment by inhalation of macromolecules--principles, problems, and examples.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():53-79. PubMed ID: 19218633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
    Kunkel G; Chuchalin AG
    Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.